PRKDC has emerged as a radiotherapy resistance driver gene in GBM from a OCT perturb-seq screen, and a driver of chemotherapy resistance in neuroblastoma in a targeted CRISPR screen [40, 78]. Here, PRKDC is linked to glioblastoma.